American Healthcare REIT, Inc. (AHTR US) · 10+ Years of Financial statements

Income Statement	2020 Y	2021 Y	2022 Y	2023 Y
Sales/Revenue/Turnover	1,189	1,265	1,618	1,859
+ Sales & Services Revenue	1,189	1,265	1,618	1,859
- Cost of Revenue	1,026	1,069	1,341	1,560
+ Cost of Goods & Services	1,026	1,069	1,341	1,560
Gross Profit	163	196	276	299
+ Other Operating Income	- -	- -	- -	- -
- Operating Expenses	71	159	186	223
+ Selling, General & Admin	27	43	43	48
+ Research & Development	- -	- -	- -	- -
+ Other Operating Expense	44	116	142	175
Operating Income (Loss)	92	37	91	77
- Non-Operating (Income) Loss	87	89	163	153
+ Interest Expense, Net	71	81	106	163
+ Interest Expense	71	81	106	163
- Interest Income	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	15	8	57	-10
Pretax Income	6	-52	-73	-76
- Income Tax Expense (Benefit)	-3	1	1	1
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	9	-53	-73	-77
- Net Extraordinary Losses (Gains)	13	-11	16	-11
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	13	-11	16	-11
Income (Loss) Incl. MI	-5	-42	-89	-66
- Minority Interest	-7	5	-8	5
Net Income, GAAP	2	-48	-81	-71
- Preferred Dividends	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	2	-48	-81	-71
Basic Weighted Avg Shares	66	66	66	66
Basic EPS, GAAP	0.03	-0.72	-1.23	-1.08
Basic EPS from Cont Ops	0.13	-0.8	-1.11	-1.16
Diluted Weighted Avg Shares	66	66	66	66
Diluted EPS, GAAP	0.03	-0.72	-1.23	-1.08
Diluted EPS from Cont Ops	0.13	-0.8	-1.11	-1.16
EBITDA	222	194	291	314
EBITDA Margin (%)	18.67	15.36	18	16.89
EBITA	92	37	91	77
EBIT	92	37	91	77
Gross Margin (%)	13.72	15.52	17.08	16.1
Operating Margin (%)	7.77	2.92	5.6	4.13
Profit Margin (%)	0.18	-3.78	-5.03	-3.84
Sales per Employee	- -	- -	14,314,159	16,901,300
Dividend per Share	0.41	0.34	0.77	1.15
Depreciation Expense	130	157	201	237

Balance Sheet	2020 Y	2021 Y	2022 Y	2023 Y
Total Current Assets	- -	267	269	297
+ Cash, Cash Equivalents & STI	- -	82	65	43
+ Cash & Cash Equivalents	- -	82	65	43
+ ST Investments	- -	- -	- -	- -
+ Accounts & Notes Receiv	- -	123	138	185
+ Accounts Receivable, Net	- -	123	138	185
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	19	20	19
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	19	20	19
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	- -	44	47	49
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
+ Misc ST Assets	- -	- -	- -	- -
Total Noncurrent Assets	- -	4,313	4,518	4,281
+ Property, Plant & Equip, Net	- -	158	276	228
+ Property, Plant & Equip	- -	158	276	228
- Accumulated Depreciation	- -	- -	- -	- -
+ LT Investments & Receivables	- -	95	93	108
+ LT Investments	- -	95	93	108
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	- -	4,060	4,149	3,945
+ Total Intangible Assets	- -	459	468	415
+ Goodwill	- -	210	232	235
+ Other Intangible Assets	- -	249	236	180
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	- -	3,601	3,681	3,530
Total Assets	- -	4,580	4,787	4,578
+ Payables & Accruals	- -	188	244	243
+ Accounts Payable	- -	187	244	243
+ Accrued Taxes	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	- -	1	- -	- -
+ ST Debt	- -	1,227	1,282	1,224
+ ST Borrowings	- -	1,227	1,282	1,224
+ ST Finance Leases	- -	145	273	226
+ Other ST Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	- -	- -	- -	- -
Total Current Liabilities	- -	1,415	1,526	1,467
+ LT Debt	- -	1,275	1,551	1,570
+ LT Borrowings	- -	1,129	1,278	1,344
+ LT Finance Leases	- -	145	273	226
+ Other LT Liabilities	- -	61	60	82
+ Accrued Liabilities	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	- -	61	60	82
Total Noncurrent Liabilities	- -	1,336	1,612	1,652
Total Liabilities	- -	2,751	3,137	3,119
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Share Capital & APIC	- -	2,535	2,541	2,549
+ Common Stock	- -	1	1	1
+ Additional Paid in Capital	- -	2,534	2,540	2,548
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	- -	-951	-1,138	-1,276
+ Other Equity	- -	-2	-3	-2
Equity Before Minority Interest	- -	1,581	1,400	1,270
+ Minority/Non Controlling Interest	- -	248	249	189
Total Equity	- -	1,830	1,649	1,459
Total Liabilities & Equity	- -	4,580	4,787	4,578
Shares Outstanding	66	66	66	66
Capital Leases - Total	- -	291	546	451
Net Debt	- -	2,274	2,495	2,525
Net Debt to Equity	- -	124.31	151.27	173.02
Tangible Common Equity Ratio	- -	33.26	27.36	25.08
Current Ratio	- -	0.19	0.18	0.2
Cash Conversion Cycle	- -	-10.47	-23.99	-20.67
Number of Employees	- -	- -	113	110

Cash Flow Statement	2020 Y	2021 Y	2022 Y	2023 Y
+ Net Income	9	-53	-73	-77
+ Depreciation & Amortization	130	157	201	237
+ Non-Cash Items	6	7	58	-6
+ Stock-Based Compensation	-1	10	4	5
+ Deferred Income Taxes	-3	- -	- -	- -
+ Asset Impairment Charge	11	3	78	24
+ Other Non-Cash Adj	- -	-6	-23	-36
+ Chg in Non-Cash Work Cap	74	-93	-38	-56
+ (Inc) Dec in Accts Receiv	20	4	-4	-35
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	- -	- -
+ Inc (Dec) in Accts Payable	35	-40	14	15
+ Inc (Dec) in Other	18	-57	-47	-36
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	219	18	148	99
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	-128	-80	-72	-100
+ Acq of Fixed Prod Assets	-128	-80	-72	-100
+ Acq of Intangible Assets	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -
+ Dec in LT Investment	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	- -
+ Net Cash From Acq & Div	-1	-1	-19	-13
+ Cash from Divestitures	- -	- -	- -	- -
+ Cash for Acq of Subs	-1	-1	-19	-13
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	-19	-58	-28	122
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	-148	-139	-119	9
+ Dividends Paid	-27	-23	-51	-76
+ Net Cash From Debt	42	146	63	-18
+ Cash From Debt	216	350	1,306	578
+ Repayments of Debt	-174	-203	-1,244	-596
+ Cash (Repurchase) of Equity	-23	- -	-21	- -
+ Increase in Capital Stock	- -	- -	- -	- -
+ Decrease in Capital Stock	-23	- -	-21	- -
+ Other Financing Activities	-1	-29	-34	-35
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	-9	94	-43	-129
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	62	-27	-14	-21
Capital Expenditures	-128	-80	-72	-100
EBITDA	222	194	291	314
EBITDA Margin (%)	18.67	15.36	18	16.89
Net Cash Paid for Acquisitions	1	1	19	13
Free Cash Flow	91	-62	76	-1
Free Cash Flow to Firm	- -	- -	- -	- -
Free Cash Flow to Equity	- -	85	139	-19
Free Cash Flow per Basic Share	1.38	-0.93	1.15	-0.02
Price/Free Cash Flow	- -	- -	- -	4.83
Cash Flow to Net Income	101.32	-0.37	-1.82	-1.38

American Healthcare REIT, Inc.

AHTR US

10.96

10.96